(Q51352565)

4 April 2018

title

Inflammatory markers and metabolic syndrome among adolescents. (English)

1 reference

4 April 2018

1 reference

1 reference

M González

1

1 reference

4 April 2018

M del Mar Bibiloni

2

1 reference

4 April 2018

A Pons

3

1 reference

4 April 2018

I Llompart

4

1 reference

4 April 2018

J A Tur

5

1 reference

4 April 2018

publication date

22 August 2012

1 reference

4 April 2018

European Journal of Clinical Nutrition

published in

1 reference

4 April 2018

volume

66

1 reference

4 April 2018

issue

10

1 reference

4 April 2018

page(s)

1141-1145

1 reference

4 April 2018

https://scigraph.springernature.com/pub.10.1038/ejcn.2012.112

exact match

0 references

cites work

Epidemic increase in overweight and obesity in Chinese children from 1985 to 2005.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

The relationship between serum adiponectin, tumor necrosis factor-alpha, leptin levels and insulin sensitivity in childhood and adolescent obesity: adiponectin is a marker of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

Components of the metabolic syndrome predictive of its development: a 6-year longitudinal study in Hong Kong Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

Prevalence of risk factors for metabolic syndrome in adolescents: National Health and Nutrition Examination Survey (NHANES), 2001-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

Obesity and the metabolic syndrome in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

Adiponectin: a key adipocytokine in metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

Adiponectin--journey from an adipocyte secretory protein to biomarker of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

Leptin: obesity, diabetes and other peripheral effects--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

Metabolic, inflammatory, endothelial and haemostatic markers in a group of Italian obese children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

Plasminogen activator inhibitor type 1 (PAI-1) is a valuable biomarker for predicting the metabolic syndrome (MS) in institutionalized elderly residents in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

Diabese youngsters have 3.7 more chances in developing metabolic syndrome compared with the obese

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

The metabolic syndrome and cardiovascular disease: Part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

Clinical use of high sensitivity C-reactive protein for the prediction of adverse cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

Metabolic syndrome in adolescents in the Balearic Islands, a Mediterranean region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

On the use of a continuous metabolic syndrome score in pediatric research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

21 January 2018

Assessing the airways

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

Elevated blood pressure, obesity, and hyperlipidemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

Overweight and obesity in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

Plasma adiponectin levels and risk of myocardial infarction in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

The role of the novel adipocyte-derived hormone adiponectin in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

Mechanisms regulating energy metabolism by adiponectin in obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

Adiponectin and vascular properties in obese patients: is it a novel biomarker of early atherosclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

Usefulness of serum adiponectin level as a diagnostic marker of metabolic syndrome in obese Japanese children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

Adiponectin is a candidate marker of metabolic syndrome in obese children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

Gender differences in C-reactive protein, interleukin-1 receptor antagonist and adiponectin levels in the metabolic syndrome: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

Serum leptin levels in overweight children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

Physical activity and social status in adolescence as predictors of physical inactivity in adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

Is social desirability associated with self-reported physical activity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

Dietary and other lifestyle characteristics of Cypriot school children: results from the nationwide CYKIDS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

Television watching, videogames, and excess of body fat in Spanish adolescents: The AVENA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

Prevalence of the metabolic syndrome in Zhejiang Chinese obese children and adolescents and the effect of metformin combined with lifestyle intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

7 January 2021

Adiponectin in childhood and adolescent obesity and its association with inflammatory markers and components of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

7 January 2021

Adiponectin as a biomarker of the metabolic syndrome in children and adolescents

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

7 January 2021

Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

7 January 2021

Concurrent validity of a modified version of the International Physical Activity Questionnaire (IPAQ-A) in European adolescents: The HELENA Study.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

7 January 2021

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

7 January 2021

Obesity in children and adolescents

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

7 January 2021

Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

7 January 2021

Associations between physical activity and fat mass in adolescents: the Stockholm Weight Development Study

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2012.112

7 January 2021

Identifiers

DOI

10.1038/EJCN.2012.112

1 reference

4 April 2018

1 reference

4 April 2018